0001140361-22-000059.txt : 20220103 0001140361-22-000059.hdr.sgml : 20220103 20220103085813 ACCESSION NUMBER: 0001140361-22-000059 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220103 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20220103 DATE AS OF CHANGE: 20220103 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kinnate Biopharma Inc. CENTRAL INDEX KEY: 0001797768 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824566526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39743 FILM NUMBER: 22500539 BUSINESS ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8582994699 MAIL ADDRESS: STREET 1: 11975 EL CAMINO REAL, STE 101 CITY: SAN DIEGO STATE: CA ZIP: 92130 8-K 1 ny20001521x2_8k.htm 8-K

Washington, D.C. 20549


Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)
January 3, 2022

(Exact name of registrant as specified in its charter)

(State or other jurisdiction
of incorporation)
File Number)
(IRS Employer
Identification No.)

3611 Valley Centre Drive, Suite 175
San Diego, CA 92130
(Address, including zip code, of Registrant’s principal executive offices)

(858) 299-4699
(Registrant’s telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Name of each exchange
on which registered
Common Stock, par value $0.0001 per share
The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Item 1.01.
Entry into a Material Definitive Agreement.

On January 3, 2022, Kinnate Biopharma Inc. (the “Company”) entered into a sales agreement (the “Sales Agreement”) with SVB Leerink LLC (“SVB Leerink”), pursuant to which the Company may offer and sell shares of the Company’s common stock, par value $0.0001 per share, from time to time, through an “at the market offering” program under which SVB Leerink will act as sales agent.  Pursuant to the sales agreement prospectus supplement included in the Company’s Form S-3 filed on January 3, 2022, the Company may offer and sell common stock having aggregate gross sales proceeds of up to $150 million.

Under the Sales Agreement, the Company will set the parameters for the sale of shares, including the number or dollar value of shares to be issued, the time period during which sales are requested to be made, limitation on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. Subject to the terms and conditions of the Sales Agreement, SVB Leerink may sell the shares by methods deemed to be an “at the market offering” as defined in Rule 415(a)(4) promulgated under the Securities Act of 1933, as amended (the “Securities Act”). SVB Leerink will use commercially reasonable efforts in conducting such sales activities consistent with its normal trading and sales practices, on mutually agreed terms between SVB Leerink and the Company. The Company is not obligated to sell, and SVB Leerink is not obligated to sell, any shares of common stock under the Sales Agreement. No assurance can be given that the Company will sell any shares of common stock under the Sales Agreement, or, if it does, as to the price or amount of shares of common stock that it sells or the dates when such sales will take place. The Sales Agreement may be terminated by either party by giving ten trading days’ prior written notice to the other party for any reason, subject to further qualifications as described in the Sales Agreement.

The Sales Agreement provides that SVB Leerink will be entitled to compensation for its services equal to up to 3.0% of the gross proceeds of any shares sold through SVB Leerink under the Sales Agreement. SVB Leerink and the Company have no obligation to sell any shares under the Sales Agreement and may at any time, upon notice to the other party, suspend solicitation and offers under the Sales Agreement.

In the Sales Agreement, the Company has agreed to indemnify SVB Leerink against certain liabilities, including under the Securities Act and to contribute payments that SVB Leerink may be required to make because of such liabilities. Further, SVB Leerink agreed to indemnify the Company, the Company’s board of directors and its executive officers against certain liabilities, including under the Securities Act.

The shares of common stock sold pursuant to the Sales Agreement will be issued pursuant to the Company’s shelf registration statement on Form S-3, including the prospectus supplement contained therein, filed with the Securities and Exchange Commission (the “SEC”) on January 3, 2022, which was automatically effective upon filing with the SEC.

The foregoing description of the Sales Agreement is not complete and is qualified in its entirety by reference to the full text of such agreement, a copy of which is filed herewith as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated herein by reference.

This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein, nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Item 9.01.
Financial Statements and Exhibits.

(d)          Exhibits.

Exhibit No.
Sales Agreement, between the Company and SVB Leerink LLC, dated as of January 3, 2022, filed as Exhibit 1.2 to the Company’s Registration Statement on Form S-3ASR, filed with the Securities and Exchange Commission on January 3, 2022 and incorporated herein by reference.
  Cover page interactive date file (embedded within the inline XBRL document).


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ Nima Farzan
Nima Farzan
President and Chief Executive Officer

Date: January 3, 2022

EX-101.SCH 2 knte-20220103.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 knte-20220103_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Emerging Growth Company Entity Ex Transition Period Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name EX-101.PRE 4 knte-20220103_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.21.4
Document and Entity Information
Jan. 03, 2022
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 03, 2022
Entity Registrant Name KINNATE BIOPHARMA INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39743
Entity Tax Identification Number 82-4566526
Entity Address, Address Line One 3611 Valley Centre Drive
Entity Address, Address Line Two Suite 175
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92130
City Area Code 858
Local Phone Number 299-4699
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001797768
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol KNTE
Security Exchange Name NASDAQ
XML 6 ny20001521x2_8k_htm.xml IDEA: XBRL DOCUMENT 0001797768 2022-01-03 2022-01-03 false 0001797768 8-K 2022-01-03 KINNATE BIOPHARMA INC. DE 001-39743 82-4566526 3611 Valley Centre Drive Suite 175 San Diego CA 92130 858 299-4699 false false false false Common Stock, par value $0.0001 per share KNTE NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.4 html 1 118 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://kinnate.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports ny20001521x2_8k.htm knte-20220103.xsd knte-20220103_lab.xml knte-20220103_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ny20001521x2_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "inline": { "local": [ "ny20001521x2_8k.htm" ] }, "labelLink": { "local": [ "knte-20220103_lab.xml" ] }, "presentationLink": { "local": [ "knte-20220103_pre.xml" ] }, "schema": { "local": [ "knte-20220103.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 118, "memberCustom": 0, "memberStandard": 0, "nsprefix": "knte", "nsuri": "http://kinnate.com/20220103", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "ny20001521x2_8k.htm", "contextRef": "c20220103to20220103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://kinnate.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "ny20001521x2_8k.htm", "contextRef": "c20220103to20220103", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://kinnate.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 13 0001140361-22-000059-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-22-000059-xbrl.zip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